Updated: 07 Jan 2001
1 Kps. enth.: Tanninalbuminat 250 mg.
The Chronic Lymphocytic Leukaemia (CLL) Knowledge Centre contains useful information arranged within four main sections: ‘Disease Awareness’, ‘Events’, ‘Resources’, and 'CME'. Healthcare professionals will find information on pathophysiology, signs and symptoms of CLL, diagnosis, prognosis, treatment and management options, an upcoming events calendar and an external links listing,
The CME activity ‘Treatment Optimisation in Chronic Lymphocytic Leukaemia’ has been EACCME-accredited and awarded 1 CME credit. Test your knowledge by answering quiz questions based on patient case study scenarios.
The Oral Anticoagualtion Reversal Knowledge Centre is intended to provide healthcare professionals with accurate information on the approaches to oral anticoagulation reversal for patients who experience or are at risk of significant bleeding, or require surgery. Content is arranged within illustrated and referenced sections including management of bleeding risk, oral anticoagulants, symposium highlights, key publication summaries and more.
This resource is developed by EPG Health Media (Europe) Ltd for epgonline.org in collaboration with CSL Behring, with content provided by CSL Behring.
This resource is not intended for healthcare professionals outside Europe.
Gelatine, Farbstoffe E 171, E 172.
Zus.: 1 Tbl. enth.: Tanninalbuminat 500 mg.
Weit. Bestandteile: Gelatine, hochdisperses Siliciumdioxid, Stearinsäure.
Überempfindlichkeit gegenüber Ovalbuminanteil.
Strenge Ind.-Stellung in den ersten 3 Mon. Gr 2 .
See disease awareness facts and stats, information on sebelipase alfa (the first and only licensed treatment for LAL-D) and resources section, including expert video channel…